3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
12
Carcinoma, Non-Small-Cell Lung
8
Uterine Cervical Neoplasms
6
Carcinoma, Renal Cell
5
Rectal Neoplasms
4
Pancreatic Neoplasms
4
Colonic Neoplasms
4
Sarcoma
3
Neoplasms
3
Lymphoma
3
Lung Neoplasms
3
Hodgkin Disease
3
Breast Neoplasms, Male
3
Thyroid Neoplasms
2
Thyroid Cancer, Papillary
2
Oropharyngeal Neoplasms
2
Liver Neoplasms
2
Kidney Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Hepatocellular
2
Adenocarcinoma, Follicular
2
von Hippel-Lindau Disease
1
Vaginal Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Tongue Neoplasms
1
Stomach Neoplasms
1
Stage III Lung Non-Small Cell Cancer AJCC v7
1
Squamous Cell Carcinoma of Head and Neck
1
Spinal Cord Neoplasms
1
Interventions
Gemcitabine
7
Cisplatin
5
Ramucirumab
3
Platinum
3
Paclitaxel
3
Docetaxel
3
1,2-diaminocyclohexaneplatinum II citrate
3
pembrolizumab
2
Carboplatin
2
rucaparib
1
pegfilgrastim
1
pazopanib
1
eribulin
1
enzalutamide
1
enfortumab vedotin
1
dehydroftorafur
1
cabozantinib
1
avelumab
1
atezolizumab
1
aflibercept
1
Taxes
1
Surgical Procedures, Operative
1
Sunitinib
1
Standard of Care
1
Specimen Handling
1
Sorafenib
1
Radiotherapy
1
Radiation
1
N-(3-aminopropyl)-N-(1-(5-benzyl-3-methyl-4-oxo-(1,2)thiazolo(5,4-d)pyrimidin-6-yl)-2-methylpropyl)-4-methylbenzamide
1
Mitozytrex
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Urethral Neoplasms
×
Fluorodeoxyglucose F18
×
Clear all
No trials found.